2024 annual financial data
Tvardi Therapeutics 2024 Net margin
Direct answer
Net margin was -992.95%.
Operating income was -55,781,000 USD and net income was -70,867,000 USD.
Operating cash flow was -60,917,000 USD.
Get free Tvardi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,137,000 USD
- Operating income
- -55,781,000 USD
- Net income
- -70,867,000 USD
- Operating cash flow
- -60,917,000 USD